Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

Showing 201 to 250 of 258

TitleReference numberPublishedLast updated
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancerTA285
Irreversible electroporation for treating primary lung cancer and metastases in the lungIPG441
Irreversible electroporation for treating renal cancerIPG443
Neutropenic sepsis: prevention and management in people with cancerCG151
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancerTA263
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2TA257
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancerTA258
Focal therapy using cryoablation for localised prostate cancerIPG423
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapyTA242
Breast reconstruction using lipomodelling after breast cancer treatmentIPG417
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancerTA118
Fulvestrant for the treatment of locally advanced or metastatic breast cancerTA239
Laparoscopic cryotherapy for renal cancerIPG405
Percutaneous cryotherapy for renal cancerIPG402
Ambulight PDT for the treatment of non-melanoma skin cancerMTG6
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancerTA227
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancerTA214
Percutaneous radiofrequency ablation for primary or secondary lung cancersIPG372
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancerTA212
Trastuzumab for the treatment of HER2-positive metastatic gastric cancerTA208
Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancerIPG356
Percutaneous radiofrequency ablation for renal cancerIPG353
Capecitabine for the treatment of advanced gastric cancerTA191
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancerTA192
Topotecan for the treatment of relapsed small-cell lung cancerTA184
Topotecan for the treatment of recurrent and stage IVB cervical cancerTA183
Pemetrexed for the first-line treatment of non-small-cell lung cancerTA181
Ex-vivo hepatic resection and reimplantation for liver cancerIPG298
Endoscopic mastectomy and endoscopic wide local excision for breast cancerIPG296
Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excisionIPG268
Laparoscopic gastrectomy for cancerIPG269
Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal)TA148
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neckTA145
Pemetrexed for the treatment of non-small-cell lung cancerTA124
Palliative photodynamic therapy for advanced oesophageal cancerIPG206
Gemcitabine for the treatment of metastatic breast cancerTA116
Photodynamic therapy for early-stage oesophageal cancerIPG200
Laparoscopic surgery for colorectal cancerTA105
Docetaxel for the treatment of hormone-refractory metastatic prostate cancerTA101
High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancerIPG174
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancerTA100
Laparoscopic retroperitoneal lymph node dissection for testicular cancerIPG158
Endoscopic axillary lymph node retrieval for breast cancerIPG147
Photodynamic therapy for localised inoperable endobronchial cancerIPG137
Cryotherapy as a primary treatment for prostate cancerIPG145
Improving outcomes in children and young people with cancerCSG7
Low dose rate brachytherapy for localised prostate cancerIPG132
Photodynamic therapy for bile duct cancerIPG134
Cryotherapy for recurrent prostate cancerIPG119
Guidance on the use of paclitaxel in the treatment of ovarian cancerTA55

Results per page

  1. 10
  2. 25
  3. 50
  4. All